| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Jun―05 |
COVID-19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune-Virological Features |
Luca Foroghi Biland, Andrea Di Lorenzo, Francesco De Maria, Gianmarco Muratore, Mirko Compagno, Laura Campogiani, et al. (+5) Luigi Coppola, Elisabetta Teti, Vincenzo Malagnino, Marco Iannetta, Loredana Sarmati |
| 2 |
[GO] |
2024―Dec―24 |
The Course of COVID-19 Infection in Patients With Chronic Hepatitis Delta |
Yavuz Emre Parlar, Müge Özarı Gülnar, Beril Kırmızıgül, Genco Gençdal, Müjdat Zeybel, Onur Keskin, Cihan Yurdaydın |
| 3 |
[GO] |
2024―Jul―27 |
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic |
Maria Paola Tramonti Fantozzi, Luca Ceccarelli, Davide Petri, Erica De Vita, Antonello Agostini, Piero Colombatto, et al. (+25) Cristina Stasi, Barbara Rossetti, Maurizia Brunetto, Lidia Surace, Antonio Salvati, Alessia Calì, Danilo Tacconi, Claudia Bianco, David Redi, Massimiliano Fabbiani, Francesca Panza, Sauro Luchi, Sara Modica, Sara Moneta, Sarah Iacopini, Cesira Nencioni, Silvia Chigiotti, Giulia Ottaviano, Anna Linda Zignego, Pierluigi Blanc, Piera Pierotti, Elisa Mariabelli, Roberto Berni, Caterina Silvestri, Lara Tavoschi |
| 4 |
[GO] |
2024―Jun―24 |
Impact of COVID-19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study |
Jean Damascene Makuza, Stanley Wong, Richard L. Morrow, Mawuena Binka, Maryam Darvishian, Dahn Jeong, et al. (+9) Prince A. Adu, Georgine Cua, Amanda Yu, Hector A. Velásquez García, Sofia R. Bartlett, Eric Yoshida, Alnoor Ramji, Mel Krajden, Naveed Z. Janjua |
| 5 |
[GO] |
2022―Nov―12 |
Abnormal liver function tests and coronavirus disease 2019: a close relationship |
Triada Bali, Vasiliki E. Georgakopoulou, Aikaterini Kamiliou, Ioannis Vergos, Magdalini Adamantou, Stefanos Vlachos, et al. (+4) George Ermidis, Nikolaos V. Sipsas, Michael Samarkos, Evangelos Cholongitas |
| 6 |
[GO] |
2022―Nov―11 |
Reply to: “Abnormal liver function tests and coronavirus disease 2019: a close relationship” |
L. Canillas, M. Puigvehí |
| 7 |
[GO] |
2022―Sep―05 |
An
HCV
hotline facilitates Hepatitis C elimination during the
COVID
-19 pandemic |
Lukas Hartl, Mathias Jachs, David Bauer, Benedikt Simbrunner, David Chromy, Teresa Binter, et al. (+9) Lisa Steininger, Caroline Schwarz, Michael Schwarz, Lukas Burghart, Robert Strassl, Michael Trauner, Michael Gschwantler, Mattias Mandorfer, Thomas Reiberger |
| 8 |
[GO] |
2022―Jun―16 |
Follow-up evaluation of patients with liver test abnormalities detected during
SARS-CoV2
infection |
Lidia Canillas, Teresa Broquetas, José A. Carrión, Giulia Pagano, Agnès Soriano, Esther Garrido, et al. (+10) Rosa Fernández, Ana Viu, Judit Romero, Gemma Díaz, Nuria Cañete, Susana Coll, Dolores Naranjo, Xavier Bessa, Montserrat Garcia-Retortillo, Marc Puigvehí |
| 9 |
[GO] |
2021―Nov―25 |
The Impact of the First, Second, and Third Waves of COVID-19 on Hepatitis B and C Testing in Ontario, Canada |
Erin Mandel, Adriana Peci, Kirby Cronin, Camelia I. Capraru, Hemant Shah, Harry L.A. Janssen, et al. (+3) Vanessa Tran, Mia J. Biondi, Jordan J. Feld |
| 10 |
[GO] |
2021―Sep―29 |
Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: a cohort study |
Carmine Coppola, Mario Masarone, Marco Bartoli, Laura Staiano, Roberta Coppola, Pietro Torre, et al. (+4) Massimiliano Conforti, Daniela Amoruso, Ivan Gardini, Marcello Persico |
| 11 |
[GO] |
2021―Aug―05 |
COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later |
Sirina Ekpanyapong, Chalermrat Bunchorntavakul, K. Rajender Reddy |
| 12 |
[GO] |
2021―Feb―07 |
Viral hepatitis C pandemic: challenges and threats to its elimination |
Laura Krekulová, Radkin Honzák, Lee W. Riley |
| 13 |
[GO] |
2020―Nov―15 |
SARS-CoV-2 infection in patients with a normal or abnormal liver |
Giuseppe Cabibbo, Giacomo Emanuele Maria Rizzo, Caterina Stornello, Antonio Craxì |
| 14 |
[GO] |
2020―Sep―28 |
Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study |
Jian Wu, Jiong Yu, Xiaowei Shi, Wei Li, Shu Song, Liangping Zhao, et al. (+10) Xinguo Zhao, Jun Liu, Dawei Wang, Chengyuan Liu, Biao Huang, Yiling Meng, Bin Jiang, Yijun Deng, Hongcui Cao, Lanjuan Li |
| 15 |
[GO] |
2020―Sep―24 |
Low risk of hepatitis b reactivation in patients with severe COVID-19 who receive immunosuppressive therapy |
Sergio Rodríguez-Tajes, Anna Miralpeix, Josep Costa, Ester López-Suñé, Montserrat Laguno, Anna Pocurull, et al. (+3) Sabela Lens, Zoe Mariño, Xavier Forns |
| 16 |
[GO] |
2020―Jul―15 |
Clinical characteristics in patients with SARS-CoV-2/HBV co-infection |
Liping Chen, Shaoping Huang, Jingmao Yang, Xin Cheng, Zhiyin Shang, Hongzhou Lu, Jilin Cheng |
|